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cross-cultural validity in an international HIV clinical trial.
METHODS: The SDM was included in a Phase IIb/III trial to
assess symptoms perceived by HIV-1-infected treatment-naïve
patients. The cross-cultural validity of 25 language versions of
the SDM was assessed using baseline data of 759 patients from 3
treatment arms, each having received zidovudine and lamivudine
in addition to one of the following: maraviroc 300 mg QD,
maraviroc 300 mg BID (approved dose for treatment-
experienced patients) and efavirenz 600 mg QD. Given the large
number of versions, creating relatively homogeneous cultural
groups was necessary for analysis. Seven cultural groups were
deﬁned according to language and geographical considerations:
European Germanic, Polish, European Romance, Occidental
English, American Spanish, Bantu and African Indo-European.
The cross-cultural validity of the SDM was assessed by applying
ordinal logistic regressions to detect Differential Item Function-
ing (DIF), and using the STATIS approach, which explores dis-
tances between item correlation matrices. RESULTS: Most items
did not function differentially between cultural groups: only four
symptoms showed DIF (fatigue, fevers, feeling anxious and head-
ache) and the greatest cultural differences were observed for
fatigue. The African Indo-European versions of the ASDM pre-
sented the highest number of differences from the other versions.
With the STATIS approach, the Bantu and European Germanic
groups were the furthest from the Occidental English but no clear
meaningful difference was found in the expressed symptom
pattern across cultural groups. CONCLUSION: Considering the
substantial heterogeneity of cultures included in the study, these
statistical ﬁndings, together with the rigorous methodology
applied for the linguistic validation of the questionnaire, support
the cross-cultural validity of the SDM. These ﬁndings also indi-
cate that culture has a limited impact on the symptoms expressed
by HIV-1-positive individuals starting antiretroviral therapy.
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OBJECTIVE: An estimated 29% to 91% of HIV-infected
patients use complementary and alternative medications (CAM).
The objective was to identify the most commonly used CAM by
HIV-infected patients and determine the prevalence of associated
adverse events (AEs). METHODS: A single-center, prospective,
cross-sectional study was conducted from February to July 2007
via convenient sampling. Inclusion criteria were: HIV-positive
adults and using at least one CAM in the prior 12 weeks. Patient
information (including demographics, CAM use, concomitant
medication use, CAM-related AEs, purchasing behavior) was
obtained using self-administered questionnaire and personal
interview techniques. This study was approved by the institu-
tion’s IRB and informed consent was obtained prior to enroll-
ment. Descriptive statistics were performed to evaluate trends
and assess AE outcomes (SAS Version 9.0). RESULTS: One
hundred individuals participated in the survey, with a response
rate of 71.9%. Subjects were 45.0(9.9) mean(SD) years, 70%
male, 54% Black, 32% Caucasian, 8% Hispanic, and 2% Asian.
Fifty-ﬁve percent had a current/previous AIDS diagnosis.
Forty-eight different CAM were used, and 96% of respondents
were taking concomitant antiretroviral medications. The most
common CAM consumed were: cranberry juice (72%), vitamin
C (37%), green tea (34%), and garlic (8%). Most respondents
(87%) purchased herbal medications on their own, and mostly
from the grocery store (56%). Sixty-four percent of respondents
did not inform their providers about CAM use. Fifteen percent
experienced AEs that were CAM-related. Nausea and vomiting
(33%) were the most frequent AEs reported. Eighty-six percent
of subjects experiencing AEs neither consulted their physicians
nor stopped using CAM that were thought to cause the AE.
CONCLUSION: HIV-infected patients frequently use CAM con-
comitantly with traditional antiretroviral medications. Physi-
cians and pharmacists should document and provide adequate
education/counseling regarding CAM, especially for HIV-
infected patients, to prevent drug interactions and AEs. More
studies are needed regarding CAM utilization, safety, and its
economic impact.
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OBJECTIVE: Designing and testing a reliable and valid survey
for comparing HIV patients’ satisfaction with services provided
by mail order with those provided by a community pharmacy.
METHODS: Exploratory cross-sectional design using conve-
nience sample of HIV patients at a University Clinic. The satis-
faction scale was developed from previously validated instrument
(a = 0.957 & a = 0.962 for factor 1 & 2 respectively). This scale
was used for all three settings i.e. mail-order, independent, and
chain pharmacies. Practicing pharmacists, graduate students, and
pharmacy faculty assessed face and content validity. Clinical
pharmacists checked for patient ease of understanding, length,
and sensitive items. Students evaluated survey completion time.
Faculty members determined ease of understanding, time of
completion, research soundness, and objective match. Modiﬁca-
tions were made followed by data collection for six-weeks. Reli-
ability tests and item analyses were conducted. Data were entered
using SPSS v.15. RESULTS: Forty-seven surveys were completed.
Item-objective match ranged from 75–90%. Item means ranged
from 2.50 to 4.44 for factor 1 and 2.27 to 4.36 for factor 2 for
mail-order, 2.33 to 3.93 and 2.85 to 3.85 for independent, and
3.00 to 4.69 and 3.09 to 4.09 for chain. Response variability for
most items were above 0.9 using Factor ‘V’. Corrected item-total
correlations ranged from 0.484 to 0.902 and 0.606 to 0.907 for
factor 1 and 2 respectively for mail-order, 0.577 to 0.965 and
0.858 to 0.960 for independent, and -0.35 to 0.862 and 0.599 to
0.932 for chain. None of the items if deleted would increase
alpha. Cronbach’s alpha for factor 1 were 0.879 for mail, 0.960
for independent, and 0.803 for chain and for factor 2 were 0.950
for mail, 0.983 for independent, and 0.969 for chain. CONCLU-
SION: Analysis indicates good face and content validity, and high
reliability. Item analyses indicate items are well written and have
good response location, variability, and discrimination.
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OBJECTIVE: To estimate the rate of progression to cirrhosis for
those infected with Chronic Hepatitis C virus (HCV) through
Abstracts A105
injection drug use (IDU) in order to inform health care policy.
METHODS: Systematic review of the literature identiﬁed articles
with information on the mean duration of infection and the
prevalence of cirrhosis for those who obtained HCV infection
through IDU. Data on mean age, mean alanine aminotransferase
(ALT) enzyme levels, proportion male, proportion with HIV
co-infection, proportion with alcohol abuse, and study setting
(academic liver clinic, community-based clinic or addiction
therapy) were abstracted. Summary progression rates were esti-
mated using random effects Poisson meta-regression, ﬁtted with
WinBUGS software. Uninformative prior distributions were
used. The impact of study co-variates on the progression rate was
assessed by estimating the posterior probability that the relative
risk (RR) exceeds 1.0. RESULTS: Systematic review identiﬁed
5225 abstracts. Abstract review identiﬁed 459 relevant articles
and a total of 41 articles met the inclusion criteria. Each of the 41
studies had a retrospective study design. The progression rate
estimate (adjusted for all co-variates) was 11.2 per 1000 person-
years (95% Credible Region, 4.9 to 27.2 per 1000 person-years)
corresponding to a 20-year cirrhosis prevalence of 20.2% for
patients with chronic HCV infection, in a community-based
clinic/addiction therapy setting, in which patients at advanced
stage of disease are excluded. Faster progression was associated
with a greater proportion male and a greater proportion with
alcohol abuse, but not a greater proportion co-infected with
HIV (probability RR > 1 = 0.90, 0.84, and 0.56, respectively).
Two studies (one with a large sample size) that demonstrated no
difference in prognosis associated with HIV co-infection may
explain this counterintuitive result. CONCLUSION: Progression
rate estimates for patients who contracted HCV through sub-
stance abuse are similar to estimates derived from post-
transfusion or liver clinic cohorts.
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OBJECTIVE: Patients seen in a hospital emergency department
(ED) require acute care. There is no time to culture an infection
for a speciﬁc antibiotic. Therefore, broad spectrum antibiotics
are used most commonly for the unknown infections. It is the
purpose of this project to examine physician choices of antibiot-
ics, and the patient conditions for which they are prescribed.
METHODS: Data was collected in a mid-sized, urban hospital
for a six month period. All antibiotics prescribed to the patients
during this time period were recorded, a total of approximately
3100 prescriptions. Because the patients have very different com-
plaints in the ED, it is difﬁcult to isolate speciﬁc diagnoses to
determine whether different diagnoses result in different antibi-
otic prescriptions. To handle this problem, we reduce the patient
diagnoses to ten clusters to determine whether there is uniformity
of prescribing within the clusters. RESULTS: Levaquin was pre-
scribed for approximately 40% of the patients receiving anti-
biotics in the hospital ED followed by Azithromycin and
Cefotaxime at 10%. Vancomycin was used for 8% of the anti-
biotic prescriptions as was Piperacillin/Taxobactam (Zosyn).
However, the prescriptions were not uniform across physicians.
In particular, one physician favored Zosyn over Levaquin while
another used as much Cipro as Levaquin. A total of eight anti-
biotics account for 96% of the total use. Two of the least used
include Linezolid and Tobramycin, both of which are expensive
and should have a deﬁnite culture to support use. Although
physicians differed considerably in their prescribing habits, there
was no statistical difference in the patient conditions treated.
CONCLUSION: Different physicians have different antibiotic
prescribing habits. It is important to examine the prescribing to
reach a consensus of best practices in the ED.
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OBJECTIVE: Due to the increasing costs for antibiotics and
increasing resistance in Slovakia the educative project S-MedDial
was established in the cooperation with professional companies,
under the guarantee of the General Health Insurance Fund. The
project evaluates prescription habits in respiratory infections,
monitors antibiotics resistance for main bacterial pathogens and
provides individual feedback to paediatrists with the aim to
rationalize the antibiotics prescription and to decrease the resis-
tance risk. METHODS: Antibiotic prescription habits were
analysed from 2003 to 2006 for 73 doctors in 5 region based on
both the prospective data from protocols (14537 protocols in
y.2006) and the retrospective claims insurance data. Analysis was
based on the established comparison system of prescription pro-
ﬁles and individual feedback was provided to each practitioner
during regional meetings of project members. RESULTS: Every
second child with respiratory infection was treated with antibi-
otics. In the whole patient group the most frequently indicated
drugs were macrolides (25.9%), followed by basic penicillins
(20.4%) and penicillins potentiated with beta-lactamase inhibi-
tors (19.9%). Macrolides were most frequently prescribed in
region Bratislava (37.3%) and Nitra (35.4%). In region Presov
there were aminopenicillins potentiated with beta-lactamase
inhibitors indicated mostly (22.5%), in Trebisov broad-spectrum
penicillins (28.4%) and in Zvolen basic penicillins (30%). From
macrolides the most frequently prescribed was azitromycin fol-
lowed by claritromycin. In all cooperating regions the antibiotics
costs were reduced by 5.1% per patient. Signiﬁcant differences in
antibiotics prescription in regions were not only in the number of
indicated antibiotics but also in their spectrum. The usage of
antibiotics in the prospective study was decrease the most in
Presov, from 67.8 % to 49.6%. CONCLUSION: S-MedDial
project represents an option for increase of antibiotics prescrip-
tion quality while using the prescribing practitioners’ education.
Analysis of antibiotics prescription habits is suitable not only for
cost control but also for antibiotics prescription implications on
resistance trends.
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OBJECTIVE: To assess the availability and accessibility of acy-
clovir in the public and private sectors of eight sub-Saharan
African countries. METHODS: A qualitative study was carried
out in Botswana, Kenya, Malawi, South Africa, Tanzania,
Uganda, Zambia and Zimbabwe over a 2-month period. Two
standardised questionnaires were used: one targeting Ministry of
Health ofﬁcials to elicit information on drug procurement and
distribution in the public sector including treatment policies for
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